Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
According to Boston Scientific's latest financial reports the company has a price-to-book ratio of 9.10442.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 6.07 | 40.04% |
2023-12-31 | 4.34 | 14.99% |
2022-12-31 | 3.77 | 3.56% |
2021-12-31 | 3.64 | 9.63% |
2020-12-31 | 3.32 | -26.92% |
2019-12-31 | 4.55 | -18.94% |
2018-12-31 | 5.61 | 15.51% |
2017-12-31 | 4.85 | 10.98% |
2016-12-31 | 4.37 | 11.33% |
2015-12-31 | 3.93 | 44.24% |
2014-12-31 | 2.72 | 12.07% |
2013-12-31 | 2.43 | 114.96% |
2012-12-31 | 1.13 | 62.27% |
2011-12-31 | 0.6968 | -31.63% |
2010-12-31 | 1.02 | -7.8% |
2009-12-31 | 1.11 | 25.3% |
2008-12-31 | 0.8822 | -23.21% |
2007-12-31 | 1.15 | -30.9% |
2006-12-31 | 1.66 | -64.57% |
2005-12-31 | 4.69 | -36.41% |
2004-12-31 | 7.38 | -30.48% |
2003-12-31 | 10.6 | 49.67% |
2002-12-31 | 7.09 |